238 related articles for article (PubMed ID: 10403738)
1. Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers.
Adachi Y; Yamamoto H; Itoh F; Hinoda Y; Okada Y; Imai K
Gut; 1999 Aug; 45(2):252-8. PubMed ID: 10403738
[TBL] [Abstract][Full Text] [Related]
2. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
[TBL] [Abstract][Full Text] [Related]
3. Enhanced secretion and activation of matrilysin during malignant conversion of human colorectal epithelium and its relationship with invasive potential of colon cancer cells.
Itoh F; Yamamoto H; Hinoda Y; Imai K
Cancer; 1996 Apr; 77(8 Suppl):1717-21. PubMed ID: 8608568
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acids reduce matrilysin (matrix metalloproteinase 7) and inhibit tumor cell invasion in human colon cancer.
Adachi Y; Itoh F; Yamamoto H; Iku S; Matsuno K; Arimura Y; Imai K
Tumour Biol; 2001; 22(4):247-53. PubMed ID: 11399950
[TBL] [Abstract][Full Text] [Related]
5. Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas.
Masaki T; Matsuoka H; Sugiyama M; Abe N; Goto A; Sakamoto A; Atomi Y
Br J Cancer; 2001 May; 84(10):1317-21. PubMed ID: 11355941
[TBL] [Abstract][Full Text] [Related]
6. Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer.
Yamamoto H; Iku S; Adachi Y; Imsumran A; Taniguchi H; Nosho K; Min Y; Horiuchi S; Yoshida M; Itoh F; Imai K
J Pathol; 2003 Feb; 199(2):176-84. PubMed ID: 12533830
[TBL] [Abstract][Full Text] [Related]
7. [Genetic diagnosis of colorectal cancer].
Itoh F; Imai K
Hokkaido Igaku Zasshi; 1996 Jan; 71(1):9-14. PubMed ID: 8727369
[TBL] [Abstract][Full Text] [Related]
8. Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice.
Powell WC; Knox JD; Navre M; Grogan TM; Kittelson J; Nagle RB; Bowden GT
Cancer Res; 1993 Jan; 53(2):417-22. PubMed ID: 8417833
[TBL] [Abstract][Full Text] [Related]
9. Tumour matrilysin expression predicts metastatic potential of stage I (pT1) colon and rectal cancers.
Kurokawa S; Arimura Y; Yamamoto H; Adachi Y; Endo T; Sato T; Suga T; Hosokawa M; Shinomura Y; Imai K
Gut; 2005 Dec; 54(12):1751-8. PubMed ID: 16284286
[TBL] [Abstract][Full Text] [Related]
10. Suppression of matrilysin inhibits colon cancer cell invasion in vitro.
Yamamoto H; Itoh F; Hinoda Y; Imai K
Int J Cancer; 1995 Apr; 61(2):218-22. PubMed ID: 7705951
[TBL] [Abstract][Full Text] [Related]
11. Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo.
Witty JP; McDonnell S; Newell KJ; Cannon P; Navre M; Tressler RJ; Matrisian LM
Cancer Res; 1994 Sep; 54(17):4805-12. PubMed ID: 8062282
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic factors of colorectal cancer concerning metastases].
Yamaguchi S; Ichikawa Y; Tanaka K; Ishikawa T; Masui H; Koganei K; Eguchi K; Ike H; Ohki S; Shimada H
Gan To Kagaku Ryoho; 1996 Apr; 23(5):529-33. PubMed ID: 8678509
[TBL] [Abstract][Full Text] [Related]
13. Matrilysin as a target for chemotherapy for colon cancer: use of antisense oligonucleotides as antimetastatic agents.
Miyazaki K; Koshikawa N; Hasegawa S; Momiyama N; Nagashima Y; Moriyama K; Ichikawa Y; Ishikawa T; Mitsuhashi M; Shimada H
Cancer Chemother Pharmacol; 1999; 43 Suppl():S52-5. PubMed ID: 10357559
[TBL] [Abstract][Full Text] [Related]
14. Detection of regional lymph node metastases in colon cancer by using RT-PCR for matrix metalloproteinase 7, matrilysin.
Ichikawa Y; Ishikawa T; Momiyama N; Yamaguchi S; Masui H; Hasegawa S; Chishima T; Takimoto A; Kitamura H; Akitaya T; Hosokawa T; Mitsuhashi M; Shimada H
Clin Exp Metastasis; 1998 Jan; 16(1):3-8. PubMed ID: 9502072
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers.
Adachi Y; Yamamoto H; Itoh F; Arimura Y; Nishi M; Endo T; Imai K
Int J Cancer; 2001 Sep; 95(5):290-4. PubMed ID: 11494227
[TBL] [Abstract][Full Text] [Related]
16. Matrix-degrading metalloproteinases in tumor progression.
Matrisian LM; Wright J; Newell K; Witty JP
Princess Takamatsu Symp; 1994; 24():152-61. PubMed ID: 8983072
[TBL] [Abstract][Full Text] [Related]
17. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
18. Matrilysin is associated with progression of colorectal tumor.
Ishikawa T; Ichikawa Y; Mitsuhashi M; Momiyama N; Chishima T; Tanaka K; Yamaoka H; Miyazakic K; Nagashima Y; Akitaya T; Shimada H
Cancer Lett; 1996 Oct; 107(1):5-10. PubMed ID: 8913260
[TBL] [Abstract][Full Text] [Related]
19. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
Adachi Y; Li R; Yamamoto H; Min Y; Piao W; Wang Y; Imsumran A; Li H; Arimura Y; Lee CT; Imai K; Carbone DP; Shinomura Y
Carcinogenesis; 2009 Aug; 30(8):1305-13. PubMed ID: 19493905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
